Microsoft today announced the general availability of the open source Data API builder (DAB), which provides REST and GraphQL endpoints for Azure databases, some three years in the making. The ...

This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of The ...

Confirming it has reached 3 million weekly developers, OpenAI is massively updating its Codex developer environment via its Mac and Windows desktop apps today to bring it closer to the “Super App” the ...

For decades, academic institutions have struggled with how to prevent researchers who have committed misconduct from securing jobs at other universities while hiding the bad behaviour. A proposal ...

Microsoft unveiled .NET Aspire at the Build 2024 developer conference, describing it as an opinionated, cloud-ready stack for building observable, production ready, distributed, cloud-native ...

Generate:Biomedicines (NASDAQ: GENB), the drug developer focused on creating immunology and inflammation (I&I) and oncology treatments through its own artificial intelligence (AI)-based platform, has ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...

Supabase, a popular developer database platform, has been blocked in India — one of its key markets — TechCrunch has learned. New Delhi ordered internet providers to block its website, resulting in ...

Recently we were introduced to OpenClaw, an AI that allows users to create their own agents to control apps like email, Spotify and home controls. Now, Sam Altman has announced that OpenAI has ...

Generate Biomedicines Inc. filed for an initial public offering, joining a growing list of biotechnology firms to leap to public markets as investors embrace the sector. The Somerville, ...

While vector databases still have many valid use cases, organizations including OpenAI are leaning on PostgreSQL to get things done. In a blog post on Thursday, OpenAI disclosed how it is using the ...